New Obesity Drug Achieves 16.6% Weight Loss in Trial

A new obesity treatment from pharmaceutical company Boehringer has shown promising results, helping patients lose an average of 16.

6% of their body weight in clinical trials.

The breakthrough adds another tool to the growing arsenal of effective weight loss medications changing lives worldwide.